Top compounds associated with response to XRCC1


Feature Type Standardized
Nominal ANOVA
mRNA PFI-1 GDSC1000 pan-cancer AAC -0.13 6e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA STF-31 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 0.0004
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.1 0.0008
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0009
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.12 0.001
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.001
Download CSV